Early diagnosis and treatment of malaria Clinical Trials

1 recruitingLast updated: May 13, 2026

There is 1 actively recruiting early diagnosis and treatment of malaria clinical trial across 1 country. Studies span Phase 4. Updated daily from ClinicalTrials.gov.


Early diagnosis and treatment of malaria Trials at a Glance

1 actively recruiting trial for early diagnosis and treatment of malaria is listed on ClinicalTrialsFinder. The largest study group is Phase 4 with 1 trial. Lead sponsors running early diagnosis and treatment of malaria studies include World Health Organization Regional Office for the South-East Asia - UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) Small Grants Programme (WHO/SEARO-TDR Small Grants Programme).

Browse early diagnosis and treatment of malaria trials by phase

About Early diagnosis and treatment of malaria Clinical Trials

Looking for clinical trials for Early diagnosis and treatment of malaria? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Early diagnosis and treatment of malaria trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Early diagnosis and treatment of malaria clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.